| 1 |
31871135 | Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators. | 2020 Mar |
3 |
| 2 |
31028056 | Potential for Underestimation of d-Methylphenidate Bioavailability Using Chiral Derivatization/Gas Chromatography. | 2019 Jul |
1 |
| 3 |
27075303 | Carboxylesterase 1 Is Regulated by Hepatocyte Nuclear Factor 4α and Protects Against Alcohol- and MCD diet-induced Liver Injury. | 2016 Apr 14 |
1 |
| 4 |
25103325 | Physiologically based pharmacokinetic modeling of impaired carboxylesterase-1 activity: effects on oseltamivir disposition. | 2014 Sep |
7 |
| 5 |
23104969 | Differential influences of ethanol on early exposure to racemic methylphenidate compared with dexmethylphenidate in humans. | 2013 Jan |
2 |
| 6 |
21402502 | Enantiospecific determination of DL-methylphenidate and DL-ethylphenidate in plasma by liquid chromatography-tandem mass spectrometry: application to human ethanol interactions. | 2011 Apr 1 |
2 |
| 7 |
12773168 | Human carboxylesterase 1: from drug metabolism to drug discovery. | 2003 Jun |
1 |
| 8 |
10381793 | Binding and hydrolysis of meperidine by human liver carboxylesterase hCE-1. | 1999 Jul |
1 |
| 9 |
9311626 | Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs. | 1997 Sep |
1 |
| 10 |
7980644 | Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine. | 1994 Nov 1 |
1 |